Author

Tian Mi

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Assay:flow cytometry· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adeleye Oluwatosin AdeshakiniD· 1 shared Alexander F. Rosenberg· 1 shared Andrew N. Nemecek· 1 shared Anthony A. HighiD· 1 shared Ben YoungbloodiD· 1 shared Brian CoventryiD· 1 shared Christopher D. SchareriD· 1 shared David A. BakeriD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adeleye Oluwatosin AdeshakinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Jump-starting the T cell response in established tumors

Tyler R. McCaw, Mingyong Liu, Christopher D. Scharer, Jeremy M. Boss, Tian Mi, Alexander F. Rosenberg, Mei Li, Rebecca Christian Arend, Donald J. Buchsbaum, James M. Markert, Troy D. Randall

This study shows that entinostat enhances CD8+ T cell responses in tumors but only when administered during a specific window after T cell activation, and this effect can be restored by prior oncolytic virus treatment.

bioRxiv · Jun 1, 2026 · PreprintImmunology

Reprogramming CAR T-Cells with designed bioPROTACs

Vivek S. Peche, Sebastian Kenny, Tae Gun Kang, Brian Coventry, Tian Mi, Inna Goreshnik, Mariana Garcia Sanchez, Reid Martin, Macey Smith, Dionne K. Vafeados, Rahul S. Kathayat, Kaiwen Yu, Zuo-Fei Yuan, Long Wu, Anthony A. High, , Stephen M Gottschalk

This paper demonstrates that bioPROTACs can reprogram CAR T-cells by targeting DNMT3A, offering a tunable alternative to gene editing for enhancing T-cell function.

bioRxiv · Feb 22, 2026 · PreprintImmunology